This study is looking at a new way to remove bladder tumors using a special laser called the SOLTIVE™ Thulium Laser Fiber. This laser helps doctors remove the entire tumor in one piece (en bloc resection). Doctors want to see if this laser helps them get clear samples of the tumor for testing. This method aims to be more precise and cause fewer problems than traditional surgery. You might be able to join if you are 18 or older, have a specific type of bladder tumor (papillary) that is less than 3cm, and are having surgery at the University of Kansas Health System. The study is considered successful if the laser helps doctors get good tumor samples for diagnosis, which will be checked after 6 months.

Study design

This is an observational study with a planned enrollment of 20 participants. It is not a randomized trial, meaning participants are not assigned to different treatment groups.

What's involved

Your participation involves undergoing the SOLTIVE™ Thulium laser procedure for bladder tumor removal. Your pre-treatment evaluation and follow-up schedule will be the same as standard care.

Compensation

Not stated in the trial record.

Follow-up

The primary goal of the study is measured at 6 months after the procedure.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.